TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Xtant Medical Holdings ( (XTNT) ) has issued an update.
On July 7, 2025, Xtant Medical Holdings announced agreements to sell its Coflex and CoFix spinal implant assets and international hardware business to Companion Spine, LLC for approximately $19.2 million. The transaction, expected to close in the third quarter of 2025, aims to reduce Xtant’s debt and improve liquidity. The sale will allow Xtant to focus on its core orthobiologics business, while Companion Spine will enhance its product portfolio and global presence in spine care. The deal involves risks, including potential delays and financing uncertainties, which could impact Xtant’s operations and financial condition.
The most recent analyst rating on (XTNT) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Xtant Medical Holdings stock, see the XTNT Stock Forecast page.
Spark’s Take on XTNT Stock
According to Spark, TipRanks’ AI Analyst, XTNT is a Neutral.
The overall stock score is driven primarily by strong technical indicators and positive earnings call insights that highlight strategic advancements and revenue growth. However, the stock’s valuation is severely impacted by its negative P/E ratio and lack of dividends, reflecting profitability challenges. Financial performance remains a concern due to persistent issues with profitability and cash flow.
To see Spark’s full report on XTNT stock, click here.
More about Xtant Medical Holdings
Xtant Medical Holdings, Inc. is a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders. The company designs, develops, and commercializes a comprehensive portfolio of orthobiologics and spinal implant systems, serving the chronic and surgical wound care and sports medicine markets.
Average Trading Volume: 209,775
Technical Sentiment Signal: Sell
Current Market Cap: $93.35M
For detailed information about XTNT stock, go to TipRanks’ Stock Analysis page.